(Q54297002)

16 June 2018

MDMA

0 references

title

Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies. (English)

1 reference

16 June 2018

author name string

Matthias E. Liechti

series ordinal

1

1 reference

16 June 2018

Franz X. Vollenweider

series ordinal

2

1 reference

16 June 2018

publication date

1 December 2001

1 reference

16 June 2018

published in

Human Psychopharmacology

1 reference

16 June 2018

volume

16

1 reference

16 June 2018

issue

8

1 reference

16 June 2018

page(s)

589-598

1 reference

16 June 2018

Intravenous administration of ecstasy (3,4-methylendioxymethamphetamine) enhances cortical and striatal acetylcholine release in vivo

cites work

1 reference

A review of central 5-HT receptors and their function

21 January 2018

1 reference

Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites

21 January 2018

1 reference

High dose pimozide does not block amphetamine-induced euphoria in normal volunteers.

21 January 2018

1 reference

Dopamine ligands and the stimulus effects of amphetamine: animal models versus human laboratory data

21 January 2018

1 reference

The standardized psychometric assessment of altered states of consciousness (ASCs) in humans.

21 January 2018

1 reference

MDMA ('ecstasy') enhances basal acetylcholine release in brain slices of the rat striatum.

21 January 2018

1 reference

No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2(15)O]-positron emission tomography study

21 January 2018

1 reference

Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents

21 January 2018

1 reference

Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

21 January 2018

1 reference

Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

21 January 2018

1 reference

3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.

21 January 2018

1 reference

Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats

21 January 2018

1 reference

Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial

21 January 2018

1 reference

The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers.

21 January 2018

1 reference

Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans

21 January 2018

1 reference

Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram

21 January 2018

1 reference

Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans

21 January 2018

1 reference

Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin

21 January 2018

1 reference

Gender differences in the subjective effects of MDMA.

21 January 2018

1 reference

Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat

21 January 2018

1 reference

Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy')

21 January 2018

1 reference

Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.

21 January 2018

1 reference

Ecstasy (MDMA): a review of its possible persistent psychological effects

21 January 2018

1 reference

Separate mechanisms for behavioral, cardiovascular, and hormonal responses to dextroamphetamine in man.

21 January 2018

1 reference

Drug discrimination studies with MDMA and amphetamine

21 January 2018

1 reference

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.

21 January 2018

1 reference

Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release

21 January 2018

1 reference

Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166)

21 January 2018

1 reference

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

21 January 2018

1 reference

The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release

21 January 2018

1 reference

Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

21 January 2018

1 reference

MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.

21 January 2018

1 reference

Effects of intravenous cocaine are partially attenuated by haloperidol.

21 January 2018

1 reference

Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug

21 January 2018

1 reference

Relationship between subjective effects of cocaine and dopamine transporter occupancy.

21 January 2018

1 reference

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action

21 January 2018

1 reference

Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers

21 January 2018

1 reference

MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks

21 January 2018

1 reference

7 January 2021

Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions.

1 reference

7 January 2021

Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists

1 reference

7 January 2021

In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain

1 reference

7 January 2021

Effects of "Ecstasy" blocked by serotonin reuptake inhibitors

1 reference

7 January 2021

Ecstasy use in Australia: patterns of use and associated harm

1 reference

7 January 2021

The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6)

1 reference

7 January 2021

Panic disorder induced by large doses of 3,4-methylenedioxymethamphetamine resolved by paroxetine

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.348

1 reference

16 June 2018

PubMed ID

12404538

1 reference

16 June 2018